Renal alterations associated with L-NAME hypertension: Reversion by losartan, mibefradil and bosentan

被引：0
|
作者：
Jover, B
Demeilliers, B
Merizi, A
Mimran, A
机构：
[1] IURC, Grp Rein & Hypertens, Montpellier, France
[2] CHU Lapeyronie, Montpellier, France
来源：
JOURNAL OF HYPERTENSION | 2000年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S213 / S213
页数：1
相关论文
共 50 条
  • [1] Renal alterations in L-NAME hypertension: Influence of losartan and bosentan
    Jover, B
    Demeilliers, B
    Herizi, A
    Mimran, A
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1998, 91 (08): : 1039 - 1042
  • [2] Bosentan and Losartan ameliorate acute renal failure associated with mild but not strong nitric oxide blockade induced by L-name
    Miloradovic, Zoran
    Jerkic, Mirjana
    Jovovic, Ica
    Mihailovic-Stanojevic, Nevena
    Grujic-Milanovic, Jelica
    Stosic, Gordana
    Markovic-Lipkovski, Jasmina
    VIRCHOWS ARCHIV, 2007, 451 (02) : 154 - 154
  • [3] Renal alterations in NG-nitro-L-arginine methyl ester hypertension:: influence of losartan and bosentan
    Jover, B
    Demeilliers, B
    Herizi, A
    Mimran, A
    JOURNAL OF HYPERTENSION, 1998, 16 (07) : 1058 - 1058
  • [4] Irbesartan but not enalapril reverses alteration of renal function associated with L-NAME hypertension
    Jover, B
    Demeilliers, B
    Herizi, A
    Nisato, D
    Cazaubon, C
    Mimran, A
    JOURNAL OF HYPERTENSION, 1998, 16 : S117 - S117
  • [5] ADMA induces hypertension and renal fibrosisas L-NAME
    Mihout, F.
    Shweke, N.
    Chatziantoniou, C.
    Dussaule, J. -C.
    Ronco, P.
    Boffa, J. -J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 : 12 - 12
  • [6] Influence of irbesartan and enalapril on changes of renal function associated with the established phase of L-NAME hypertension
    Jover, B
    Herizi, A
    Casellas, D
    Mimran, A
    JOURNAL OF HYPERTENSION, 2001, 19 (11) : 2039 - 2046
  • [7] Vasodilatory mechanisms in L-NAME hypertension
    Kunes, J
    Mikova, D
    Dobesova, Z
    Bibova, J
    Hampl, V
    Zicha, J
    HYPERTENSION, 2004, 44 (04) : 566 - 566
  • [8] Angiotensin II blockade with Losartan does not prevent renal effects of L-NAME in humans.
    Montanari, A
    Tateo, E
    Fasoli, E
    Corsini, F
    Donatini, A
    Novarini, A
    DallAglio, P
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1597 - A1597
  • [9] Losartan worsens glomerular filtration during L-NAME administration in experimental postischaemic acute renal failure
    Miloradovic, Z
    Jovovic, D
    Jerkic, M
    Mihailovic-Stanojevic, N
    Stosic, G
    JOURNAL OF HYPERTENSION, 2000, 18 : S96 - S96
  • [10] A role for the thromboxane receptor in L-NAME hypertension
    Francois, Helene
    Makhanova, Natalia
    Ruiz, Philip
    Ellison, Jonathan
    Mao, Lan
    Rockman, Howard A.
    Coffman, Thomas M.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2008, 295 (04) : F1096 - F1102
12345